56 related articles for article (PubMed ID: 17922971)
1. Prognostic factors in stage III non-small-cell lung cancer.
Ademuyiwa FO; Johnson CS; White AS; Breen TE; Harvey J; Neubauer M; Hanna NH
Clin Lung Cancer; 2007 Sep; 8(8):478-82. PubMed ID: 17922971
[TBL] [Abstract][Full Text] [Related]
2. Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer.
Janjigian YY; McDonnell K; Kris MG; Shen R; Sima CS; Bach PB; Rizvi NA; Riely GJ
Cancer; 2010 Feb; 116(3):670-5. PubMed ID: 20029977
[TBL] [Abstract][Full Text] [Related]
3. Treatment patterns and long-term survival outcomes for patients with stage III non-small cell lung cancer: A retrospective study.
Kumari S; Karikios D; Yeghiaian-Alvandi R; Flynn P; Morgan L; Kay L; Ding P
Asia Pac J Clin Oncol; 2024 Feb; 20(1):25-31. PubMed ID: 36722413
[TBL] [Abstract][Full Text] [Related]
4. Endpoints in phase II trials for advanced non-small cell lung cancer.
Mandrekar SJ; Qi Y; Hillman SL; Allen Ziegler KL; Reuter NF; Rowland KM; Kuross SA; Marks RS; Schild SE; Adjei AA
J Thorac Oncol; 2010 Jan; 5(1):3-9. PubMed ID: 19884856
[TBL] [Abstract][Full Text] [Related]
5. The influence of gender, race, and marital status on survival in lung cancer patients: analysis of Radiation Therapy Oncology Group trials.
Siddiqui F; Bae K; Langer CJ; Coyne JC; Gamerman V; Komaki R; Choy H; Curran WJ; Watkins-Bruner D; Movsas B
J Thorac Oncol; 2010 May; 5(5):631-9. PubMed ID: 20432520
[TBL] [Abstract][Full Text] [Related]
6. Identification of patient characteristics associated with survival benefit from metformin treatment in patients with stage I non-small cell lung cancer.
Elkin PL; Mullin S; Tetewsky S; Resendez SD; McCray W; Barbi J; Yendamuri S
J Thorac Cardiovasc Surg; 2022 Nov; 164(5):1318-1326.e3. PubMed ID: 35469597
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of height on long-term survival of resectable lung cancer: a new feature of the lung cancer paradox.
Daffré E; Porcher R; Iannelli A; Prieto M; Brouchet L; Falcoz PE; Le Pimpec Barthes F; Pages PB; Thomas PA; Dahan M; Alifano M
Thorax; 2024 Mar; 79(4):316-324. PubMed ID: 38359923
[TBL] [Abstract][Full Text] [Related]
8. Health Services Access Inequalities in Brazil Result in Poorer Outcomes for Stage III NSCLC-RELANCE/LACOG 0118.
Cordeiro de Lima VC; Gelatti A; Moura JFP; Fares AF; de Castro G; Mathias C; Terra RM; Werutsky G; Corassa M; Araújo LHL; Cronenberger E; Fujiki FK; Reichow S; da Silva AVT; Reis TV; Padoan MLA; Pacheco P; Yamamura R; Kawamura C; Mascarenhas E; de Jesus RG; Gössling G; Baldotto C
JTO Clin Res Rep; 2024 Mar; 5(3):100646. PubMed ID: 38434771
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and associations of gout and hyperuricaemia: results from an Australian population-based study.
Ting K; Gill TK; Keen H; Tucker GR; Hill CL
Intern Med J; 2016 May; 46(5):566-73. PubMed ID: 26765205
[TBL] [Abstract][Full Text] [Related]
10. Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC.
Hindocha S; Charlton TG; Linton-Reid K; Hunter B; Chan C; Ahmed M; Greenlay EJ; Orton M; Bunce C; Lunn J; Doran SJ; Ahmad S; McDonald F; Locke I; Power D; Blackledge M; Lee RW; Aboagye EO
NPJ Precis Oncol; 2022 Oct; 6(1):77. PubMed ID: 36302938
[TBL] [Abstract][Full Text] [Related]
11. The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy followed by durvalumab in patients with unresectable stage III non-small cell lung cancer: A multicenter retrospective cohort study.
Takeda Y; Kusaba Y; Tsukita Y; Uemura Y; Miyauchi E; Yamamoto T; Mayahara H; Hata A; Nakayama H; Tanaka S; Uchida J; Usui K; Toyoda T; Tamiya M; Morimoto M; Oya Y; Kodaira T; Jingu K; Sugiura H
Clin Transl Radiat Oncol; 2022 Nov; 37():57-63. PubMed ID: 36065360
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population.
Kim HC; Ji W; Lee JC; Kim HR; Song SY; Choi CM; ;
Cancer Res Treat; 2021 Oct; 53(4):1033-1041. PubMed ID: 33592139
[TBL] [Abstract][Full Text] [Related]
13. Risk Stratification of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Chemo-Radiotherapy: An Institutional Analysis.
Sher A; Medavaram S; Nemesure B; Clouston S; Keresztes R
Cancer Manag Res; 2020; 12():7165-7171. PubMed ID: 32848470
[TBL] [Abstract][Full Text] [Related]
14. Preoperative anemia as a prognostic factor in patients with lung cancer: a systematic review and meta-analysis of epidemiological studies.
Liu Y; Bai YP; Zhou ZF; Jiang CR; Xu Z; Fan XX
J Cancer; 2019; 10(9):2047-2056. PubMed ID: 31205565
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Mean Platelet Volume on Local Advanced Non-Small Cell Lung Cancer Managed with Chemoradiotherapy.
Sakin A; Secmeler S; Arici S; Geredeli C; Yasar N; Demir C; Aksaray F; Cihan S
Sci Rep; 2019 Mar; 9(1):3959. PubMed ID: 30850724
[TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P
BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532
[TBL] [Abstract][Full Text] [Related]
17. A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients.
Stinchcombe TE; Fan W; Schild SE; Vokes EE; Bogart J; Le QT; Thomas CR; Edelman MJ; Horn L; Komaki R; Cohen HJ; Kishor Ganti A; Pang H; Wang X
Cancer; 2019 Feb; 125(3):382-390. PubMed ID: 30343497
[TBL] [Abstract][Full Text] [Related]
18. Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database.
Miller ED; Fisher JL; Haglund KE; Grecula JC; Xu-Welliver M; Bertino EM; He K; Shields PG; Carbone DP; Williams TM; Otterson GA; Bazan JG
Radiat Oncol; 2018 Oct; 13(1):196. PubMed ID: 30290823
[TBL] [Abstract][Full Text] [Related]
19. Body mass index and mortality in lung cancer patients: a systematic review and meta-analysis.
Wang J; Xu H; Zhou S; Wang D; Zhu L; Hou J; Tang J; Zhao J; Zhong S
Eur J Clin Nutr; 2018 Jan; 72(1):4-17. PubMed ID: 28513621
[TBL] [Abstract][Full Text] [Related]
20. Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies.
Stinchcombe TE; Zhang Y; Vokes EE; Schiller JH; Bradley JD; Kelly K; Curran WJ; Schild SE; Movsas B; Clamon G; Govindan R; Blumenschein GR; Socinski MA; Ready NE; Akerley WL; Cohen HJ; Pang HH; Wang X
J Clin Oncol; 2017 Sep; 35(25):2885-2892. PubMed ID: 28493811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
